Review Article

Advances in Research on the circRNA-miRNA-mRNA Network in Coronary Heart Disease Treated with Traditional Chinese Medicine

Table 3

The influence of active ingredients-miRNA in TCM on cardiovascular diseases.

Active componentsCell typesMiRNAsTargetsEffects (references)

Tanshinone IIAMacrophagesmiR-375KLF4Anti-AS [33]
NRCMsmiR-133MAPK ERK1/2Protecting cardiomyocytes [34]
H9c2miR-152-3pPTENInhibiting apoptosis [35]
SalvianolateH9c2miR-122-5pBax, Bcl-2Inhibiting apoptosis [36]
Astragaloside IVH9c2miR-23a/miR-92a.PI3K/AKTProtects rat cardiomyocytes [37]
Notoginsenoside R1H9c2miR-21PI3K/AKTCardioprotective actions [38]
Ginsenoside Rb1NRCMsmiR-208—Protecting H/I impaired NRCMs [39]
Ginkgolide BEPCmiR-126AktPromoted cell growth [40]
Crataegus special extractHUVECmiR-155eNOSProtecting vascular [41]

EPC: endothelial progenitor cells; HUVEC: human umbilical vein endothelial cells; NRCMs: neonatal rat cardiomyocytes.